Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Cardiol Young. 2009 Jun 15;19(4):320–330. doi: 10.1017/S1047951109990382

Table 1.

Demographic, anatomic, and surgical characteristics of the cohorts. All variables listed were considered in modelling as potential correlates of Fontan Functional Score, unless otherwise noted in Methods.

Study Cohort
Modelling Cohort
Validation Cohort
Variables Number missing Mean ± SD, Median (Interquartile Range) or % Mean ± SD, Median (Interquartile Range) or % Mean ± SD, Median (Interquartile Range) or % p value*
Number of subjects 476 405 71
Fontan Functional Score 49.5 ± 17.3 49.4 ± 17.7 50.0 ± 14.9 0.803
Age at enrollment, year 12.0 ± 3.4 12.0 ± 3.4 12.1 ± 3.3 0.825
Race 1 0.133
 White 382 (80.4%) 319 (79.0%) 63 (88.7%)
 Black 47 (9.9%) 44 (10.9%) 3 (4.2%)
 Other 46 (9.7%) 41 (10.1%) 5 (7.0%)
Male 287 (60.3%) 244 (60.2%) 43 (60.6%) 1.000
Parental highest grade of school 6 0.391
 Some high school or less 29 (6.2%) 22 (5.5%) 7 (10.3%)
 High school graduate or GED 117 (24.9%) 105 (26.1%) 12 (17.6%)
 Vocational school, some college 159 (33.8%) 136 (33.8%) 23 (33.8%)
 4 year college graduate 110 (23.4%) 93 (23.1%) 17 (25.0%)
 Graduate degree 55 (11.7%) 46 (11.4%) 9 (13.2%)
Household income 61 0.174
 <$20 000 52 (12.5%) 46 (12.9%) 6 (10.2%)
 $20 000–39 000 76 (18.3%) 70 (19.7%) 6 (10.2%)
 $40 000–59 000 69 (16.6%) 53 (14.9%) 16 (27.1%)
 $60 000–79 000 63 (15.2%) 54 (15.2%) 9 (15.3%)
 $80 000–99 000 58 (14.0%) 51 (14.3%) 7 (11.9%)
 >$100 000 97 (23.4%) 82 (23.0%) 15 (25.4%)
Pulmonary atresia 29 (6.1%) 25 (6.2%) 4 (5.6%) 1.000
Hypoplastic left heart syndrome 100 (21.0%) 83 (20.5%) 17 (23.9%) 0.529
Common atrioventricular valve/Heterotaxy/Unbalanced atrioventricular septal defect 52 (10.9%) 42 (10.4%) 10 (14.1%) 0.355
Tricuspid atresia 114 (24.0%) 97 (24.0%) 17 (23.9%) 1.000
Totally anomalous pulmonary venous return 8 (1.7%) 5 (1.2%) 3 (4.2%) 0.103
Ventricular type 0.671
 Left 244 (51.3%) 211 (52.1%) 33 (46.5%)
 Right 162 (34.0%) 135 (33.3%) 27 (38.0%)
 Mixed 70 (14.7%) 59 (14.6%) 11 (15.5%)
Pre-Fontan mean pulmonary arterial pressure, mmHg 43 11.4 ± 3.3 11.4 ± 3.3 11.9 ± 3.3 0.200
Pre-Fontan end-diastolic pressure, mmHg 22 7.8 ± 3.3 7.8 ± 3.4 8.0 ± 2.6 0.562
Pre-Fontan oxygen saturation, percent 13 84 ± 5.2 84.0 ± 5.0 84.3 ± 6.4 0.694
Age at volume unloading surgery (either superior cavopulmonary anatomosis or Fontan), year 6 1.0 (0.6, 2.3) 1.0 (0.6, 2.3) 1.1 (0.6, 2.2) 0.949
Superior cavopulmonary anatomosis 351 (73.7%) 297 (73.3%) 54 (76.1%) 0.770
Number of pulmonary arterial surgeries 0.4 ± 0.7 0.4 ± 0.7 0.5 ± 0.7 0.819
Moderate/Severe atrioventricular valvar regurgitation 48 20 (4.7%) 17 (4.7%) 3 (4.4%) 1.000
Moderate/Severe ventricular dysfunction 31 6 (1.4%) 5 (1.4%) 1 (1.5%) 1.000
Age at Fontan, year 2.9 (2.1, 4.0) 2.9 (2.1, 3.9) 3.0 (1.9, 5.0) 0.657
Weight for age z score at Fontan 8 −1.0 ± 1.2 −1.0 ± 1.2 −0.9 ± 1.2 0.457
Fenestration 319 (67.0%) 262 (64.7%) 57 (80.3%) 0.009
Cardpulmonary bypass time, minutes 37 113.9 ± 47.4 114.0 ± 48.1 113.0 ± 43.4 0.865
Type of Fontan 0.346
Atriopulmonary connection 67 (14.1%) 61 (15.1%) 6 (8.5%)
Total cavopulmonary connection intracardiac lateral tunnel 287 (60.3%) 244 (60.2%) 43 (60.6%)
Total cavopulmonary connection extracardiac lateral tunnel 53 (11.1%) 41 (10.1%) 12 (16.9%)
Total cavopulmonary connection extracardiac conduit 60 (12.6%) 51 (12.6%) 9 (12.7%)
Other 9 (1.9%) 8 (2.0%) 1 (1.4%)
Post-operation complication: Prolonged pleural/pericardial effusions/chylothorax 177 (37.6%) 149 (37.3%) 28 (39.4%) 0.791
Length of hospital stay, days 9 11 (9, 18) 12 (9, 18) 11 (8, 18) 0.454
Post-Fontan arrhythmia 101 (21.2%) 86 (21.2%) 15 (21.1%) 1.000
Post-Fontan surgeries ≥2 13 (2.7%) 12 (3.0%) 1 (1.4%) 0.702
Number of post-Fontan catheterization interventions 0.8 ± 1.1 0.7 ± 1.1 1.0 ± 1.2 0.107
Aortic arch repair 1 (0.2%) 0 (0.0%) 1 (1.4%) 0.149
Pulmonary arterial surgeries 4 (0.8%) 4 (0.9%) 0 (0.0%) 1.000
Number of years since Fontan 8.7 ± 3.4 8.8 ± 3.4 8.4 ± 3.7 0.398
Currently on pacemaker 64 (13.5%) 51 (12.6%) 13 (18.3%) 0.191
*

Test of significance for differences between model sample (405 subjects) and validation sample (71 subjects).